UCSD Perlman Ambulatory Center - Dermatology clinic
La Jolla, California, 92037, United States
NCT Number: NCT00970671
The purpose of this study is to determine whether treatment of fresh surgical scars with a pulsed dye laser using purpura-inducing settings will improve clinical appearance better than one using non-purpura-inducing settings or no treatment.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
La Jolla, California, 92037, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pulsed dye laser treatment at purpuric settings with pulse duration of 1.5msec.
Other names: Pulsed dye laser, 595nm VBeam, Candela
Pulsed dye laser treatment with nonpurpuric settings with pulse duration 10msec.
Other names: Pulsed dye laser, 595nm VBeam, Candela
No laser treatment
Time frame: 6weeks, 10weeks, and 18weeks after surgery
Time frame: at each treatment visit: 2weeks, 6weeks, and 10weeks after surgery
Time frame: 6weeks, 10 weeks, and 18weeks after surgery
University of California, San Diego
Other
Treatment of Surgical Scars With the 595nm Pulsed Dye Laser Using Purpuric and Nonpurpuric Parameters: A Comparative Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03888703
Accidental Injuries, Burns
View Trial DetailsNCT07673484
Allergic Contact Dermatitis, Cicatrix
Küçükçekmece, Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07441538
Cicatrix, Cyst
Wuhan, Hubei, China
View Trial DetailsNCT02234193
Cicatrix, Fibrosis
Boston, Massachusetts, United States
View Trial Details